บารมีผู้เฒ่าผู้แก่ คุ้มภัยสมองเสื่อม

thairath130510_002ศึกษาค้นพบผู้แก่ผู้เฒ่าที่มีอายุยืนๆ ยังสามารถแผ่บุญบารมีให้ช่วยคุ้มครองปกปักรักษาลูกหลานเหลนเป็นโรคสมองเสื่อมช้ากว่าคนทั่วๆไปคนอื่นได้อีกด้วย

ศูนย์แพทย์มหาวิทยาลัยโคลัมเบียของสหรัฐฯ ศึกษาพบว่าบรรดาลูกหลานว่านเครือของคนที่มีอายุยืนยงถึง 90 ปี จะพากันเป็นโรคสมองเสื่อมตอนช่วงอายุระหว่าง 65-79 ปี ช้ากว่าเพื่อนรุ่นราวคราวเดียวกันมากถึงร้อยละ 40 นักวิจัยได้ชี้แจงว่า “ไม่ใช่ว่าคนเหล่านี้จะไม่เป็นโรคนี้กันเลย หากแต่มันดูเหมือนว่าพวกเขาจะพากันมาเป็นกันทีหลังช้ากว่าคนอื่น”

คนอเมริกันผู้ที่มีอายุยืนทุกวันนี้ คือผู้ที่อยู่เกินอายุขัยเฉลี่ย อย่างเช่น ผู้ชายปัจจุบันวัย 65 ปี สามารถจะอยู่ได้จนถึงอายุ 83 ปี และผู้หญิงอาจอยู่ได้นานถึง 85 ปี ซึ่งปรากฏว่าโอกาสของการมีอายุยืนกับโอกาสที่จะเป็นโรคสมองเสื่อม ต่างสามารถถ่ายทอดทางกรรมพันธุ์ถึงกันได้พอๆกัน.

ที่มา :  ไทยรัฐ  10 พฤษภาคม 2556

.

Related Article :

.

Could Family Longevity Protect Against Dementia?

Epidemiology
Last Updated: 2013-05-07 19:22:18 -0400 (Reuters Health)

By Andrew M. Seaman

NEW YORK (Reuters Health) – The sons and daughters of people who live very long lives tend to get the symptoms of Alzheimer’s disease later than others, but they’re not immune from the disease, according to a new study.

Based on comparisons of people in their 90s, their spouses, siblings, children and their children’s spouses, researchers found that the offspring of people with exceptional longevity were about 40% less likely than peers to be cognitively impaired between ages 65 and 79.

“It’s not necessarily that these individuals never become cognitively impaired, but what it seems like is that there is a delayed onset of cognitive impairment,” said Dr. Stephanie Cosentino, of the Columbia University Medical Center in New York.

By the time members of the older generation of study volunteers were in their 90s, however, their risk of being cognitively impaired was fairly high.

So Dr. Cosentino’s team projects that the kids of these long-lived individuals will have the same risk level as their parents if they enjoy similar longevity – that is, they’ll no longer be protected.

As life expectancies continue to rise, few have investigated whether that means people live to those old ages cognitively “intact,” Dr. Cosentino and her colleagues wrote May 6th in JAMA Neurology.

For the new study, the researchers used data on cognitive impairment from 1,870 people who are part of the Long Life Family Study, which includes volunteers in New York, Massachusetts, Pennsylvania and Denmark.

In the U.S., subjects were recruited along with their (younger) siblings, their children and their siblings’ children – as well as all available spouses in both generations, who serve as an unrelated comparison group without necessarily having a family history of longevity.

The study included 1,510 people with a family history of longevity and 360 of their spouses, but for this study, researchers used information on just the volunteers who were 89 years old or older when they were recruited.

A series of tests measured the participants’ memory, recall abilities, language and processing skills.

Overall, the researchers found that about 6% of the volunteers’ children were cognitively impaired between ages 65 and 79 years old, compared to 13% of their spouses and about 11% of their cousins.

Among the study’s long-lived older generation, participants were just as likely to be cognitively impaired by about age 90 as their siblings or spouses.

“These families seem relatively protected, but once they reach extreme old age – say after 90 (years old) – their rates of cognitive impairment become comparable,” Dr. Cosentino said.

The study cannot say whether a parent’s longevity protected the offspring from becoming cognitively impaired in their 60s and 70s, but Dr. Cosentino said she and her colleagues want to know what makes them different from the others.

“Our current interest now is understanding the genetic basis of that delay,” she said, adding that the hope is they could eventually help others delay memory problems as well.

Dr. Mary Sano, director of the Alzheimer’s Disease Research Center at the Icahn School of Medicine at Mount Sinai in New York, told Reuters Health that the new study supports previous research on aging and dementia.

“This study and other studies have really shown we are moving in the direction of understanding the genetics and biology of successful aging,” said Dr. Sano, who was not involved with the new study.

“I think the reason it’s so promising is because we’ve put a lot of effort into studying diseases to find the silver bullet to prevent disease and very little work goes into people who are less likely to have the disease or less likely to develop the disease,” she said.

“I think looking at this side is critical, because we haven’t had much luck looking the other way,” Dr. Sano said.

SOURCE: http://bit.ly/128MT0j

SOURCE: www.psychcongress.com